External validation of the Donor Risk Index and the Eurotransplant Donor Risk Index on the French liver transplantation registry

Background & Aims A major limitation to liver transplantation is organ shortage leading to the use of non‐optimal liver grafts. The Donor Risk Index has been validated and recommended to select donors/organs. The Eurotransplant Donor Risk Index was derived from the Donor Risk Index. The objectiv...

Full description

Saved in:
Bibliographic Details
Published inLiver international Vol. 37; no. 8; pp. 1229 - 1238
Main Authors Winter, Audrey, Féray, Cyrille, Audureau, Etienne, Écochard, René, Jacquelinet, Christian, Roudot‐Thoraval, Françoise, Duvoux, Christophe, Daurès, Jean‐Pierre, Landais, Paul
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.08.2017
Wiley-Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background & Aims A major limitation to liver transplantation is organ shortage leading to the use of non‐optimal liver grafts. The Donor Risk Index has been validated and recommended to select donors/organs. The Eurotransplant Donor Risk Index was derived from the Donor Risk Index. The objective of our study was to perform an external validation of both Donor Risk Index and Eurotransplant‐Donor Risk Index against the French liver transplantation Cristal registry according to recommendations of the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis. Methods Liver transplantations performed in France between 2009 and 2013 were used to perform the validation study for the Donor Risk Index and the Eurotransplant‐Donor Risk Index respectively. We applied on the French data the models used to construct the Donor Risk Index and the Eurotransplant‐Donor Risk Index respectively. Results Neither the Donor Risk Index nor the Eurotransplant‐Donor Risk Index were validated against this dataset. Discrimination and calibration of these scores were not preserved according to our data. Important donor and candidates differences between our dataset and the Organ Procurement and Transplantation Network or the Eurotransplant datasets may explain why the Donor Risk Index and the Eurotransplant‐Donor Risk Index appeared unadapted to the French transplant registry. Conclusion Neither of these risk indexes were suitable to optimize the French liver allocation system. Thus, our next step will be to propose a general adaptive model for a Donor Risk Index.
AbstractList BACKGROUND & AIMSA major limitation to liver transplantation is organ shortage leading to the use of non-optimal liver grafts. The Donor Risk Index has been validated and recommended to select donors/organs. The Eurotransplant Donor Risk Index was derived from the Donor Risk Index. The objective of our study was to perform an external validation of both Donor Risk Index and Eurotransplant-Donor Risk Index against the French liver transplantation Cristal registry according to recommendations of the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis.METHODSLiver transplantations performed in France between 2009 and 2013 were used to perform the validation study for the Donor Risk Index and the Eurotransplant-Donor Risk Index respectively. We applied on the French data the models used to construct the Donor Risk Index and the Eurotransplant-Donor Risk Index respectively.RESULTSNeither the Donor Risk Index nor the Eurotransplant-Donor Risk Index were validated against this dataset. Discrimination and calibration of these scores were not preserved according to our data. Important donor and candidates differences between our dataset and the Organ Procurement and Transplantation Network or the Eurotransplant datasets may explain why the Donor Risk Index and the Eurotransplant-Donor Risk Index appeared unadapted to the French transplant registry.CONCLUSIONNeither of these risk indexes were suitable to optimize the French liver allocation system. Thus, our next step will be to propose a general adaptive model for a Donor Risk Index.
Background & Aims A major limitation to liver transplantation is organ shortage leading to the use of non‐optimal liver grafts. The Donor Risk Index has been validated and recommended to select donors/organs. The Eurotransplant Donor Risk Index was derived from the Donor Risk Index. The objective of our study was to perform an external validation of both Donor Risk Index and Eurotransplant‐Donor Risk Index against the French liver transplantation Cristal registry according to recommendations of the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis. Methods Liver transplantations performed in France between 2009 and 2013 were used to perform the validation study for the Donor Risk Index and the Eurotransplant‐Donor Risk Index respectively. We applied on the French data the models used to construct the Donor Risk Index and the Eurotransplant‐Donor Risk Index respectively. Results Neither the Donor Risk Index nor the Eurotransplant‐Donor Risk Index were validated against this dataset. Discrimination and calibration of these scores were not preserved according to our data. Important donor and candidates differences between our dataset and the Organ Procurement and Transplantation Network or the Eurotransplant datasets may explain why the Donor Risk Index and the Eurotransplant‐Donor Risk Index appeared unadapted to the French transplant registry. Conclusion Neither of these risk indexes were suitable to optimize the French liver allocation system. Thus, our next step will be to propose a general adaptive model for a Donor Risk Index.
BACKGROUND & AIMS:A major limitation to liver transplantation is organ shortage leading to the use of non-optimal liver grafts. The Donor Risk Index has been validated and recommended to select donors/organs. The Eurotransplant Donor Risk Index was derived from the Donor Risk Index. The objective of our study was to perform an external validation of both Donor Risk Index and Eurotransplant-Donor Risk Index against the French liver transplantation Cristal registry according to recommendations of the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis.METHODS:Liver transplantations performed in France between 2009 and 2013 were used to perform the validation study for the Donor Risk Index and the Eurotransplant-Donor Risk Index respectively. We applied on the French data the models used to construct the Donor Risk Index and the Eurotransplant-Donor Risk Index respectively.RESULTS:Neither the Donor Risk Index nor the Eurotransplant-Donor Risk Index were validated against this dataset. Discrimination and calibration of these scores were not preserved according to our data. Important donor and candidates differences between our dataset and the Organ Procurement and Transplantation Network or the Eurotransplant datasets may explain why the Donor Risk Index and the Eurotransplant-Donor Risk Index appeared unadapted to the French transplant registry.CONCLUSION:Neither of these risk indexes were suitable to optimize the French liver allocation system. Thus, our next step will be to propose a general adaptive model for a Donor Risk Index.
A major limitation to liver transplantation is organ shortage leading to the use of non-optimal liver grafts. The Donor Risk Index has been validated and recommended to select donors/organs. The Eurotransplant Donor Risk Index was derived from the Donor Risk Index. The objective of our study was to perform an external validation of both Donor Risk Index and Eurotransplant-Donor Risk Index against the French liver transplantation Cristal registry according to recommendations of the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis. Liver transplantations performed in France between 2009 and 2013 were used to perform the validation study for the Donor Risk Index and the Eurotransplant-Donor Risk Index respectively. We applied on the French data the models used to construct the Donor Risk Index and the Eurotransplant-Donor Risk Index respectively. Neither the Donor Risk Index nor the Eurotransplant-Donor Risk Index were validated against this dataset. Discrimination and calibration of these scores were not preserved according to our data. Important donor and candidates differences between our dataset and the Organ Procurement and Transplantation Network or the Eurotransplant datasets may explain why the Donor Risk Index and the Eurotransplant-Donor Risk Index appeared unadapted to the French transplant registry. Neither of these risk indexes were suitable to optimize the French liver allocation system. Thus, our next step will be to propose a general adaptive model for a Donor Risk Index.
Abstract Background & Aims A major limitation to liver transplantation is organ shortage leading to the use of non‐optimal liver grafts. The Donor Risk Index has been validated and recommended to select donors/organs. The Eurotransplant Donor Risk Index was derived from the Donor Risk Index. The objective of our study was to perform an external validation of both Donor Risk Index and Eurotransplant‐Donor Risk Index against the French liver transplantation Cristal registry according to recommendations of the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis . Methods Liver transplantations performed in France between 2009 and 2013 were used to perform the validation study for the Donor Risk Index and the Eurotransplant‐Donor Risk Index respectively. We applied on the French data the models used to construct the Donor Risk Index and the Eurotransplant‐Donor Risk Index respectively. Results Neither the Donor Risk Index nor the Eurotransplant‐Donor Risk Index were validated against this dataset. Discrimination and calibration of these scores were not preserved according to our data. Important donor and candidates differences between our dataset and the Organ Procurement and Transplantation Network or the Eurotransplant datasets may explain why the Donor Risk Index and the Eurotransplant‐Donor Risk Index appeared unadapted to the French transplant registry. Conclusion Neither of these risk indexes were suitable to optimize the French liver allocation system. Thus, our next step will be to propose a general adaptive model for a Donor Risk Index.
Author Féray, Cyrille
Landais, Paul
Winter, Audrey
Écochard, René
Jacquelinet, Christian
Daurès, Jean‐Pierre
Duvoux, Christophe
Audureau, Etienne
Roudot‐Thoraval, Françoise
Author_xml – sequence: 1
  givenname: Audrey
  orcidid: 0000-0002-6161-8037
  surname: Winter
  fullname: Winter, Audrey
  email: audrey.winter89@gmail.com
  organization: Languedoc Mutualité
– sequence: 2
  givenname: Cyrille
  surname: Féray
  fullname: Féray, Cyrille
  organization: Henri Mondor University Hospital
– sequence: 3
  givenname: Etienne
  surname: Audureau
  fullname: Audureau, Etienne
  organization: Henri Mondor University Hospital
– sequence: 4
  givenname: René
  surname: Écochard
  fullname: Écochard, René
  organization: CNRS 5558 ‐ LBBE
– sequence: 5
  givenname: Christian
  surname: Jacquelinet
  fullname: Jacquelinet, Christian
  organization: Agence de la Biomédecine
– sequence: 6
  givenname: Françoise
  surname: Roudot‐Thoraval
  fullname: Roudot‐Thoraval, Françoise
  organization: Henri Mondor University Hospital
– sequence: 7
  givenname: Christophe
  surname: Duvoux
  fullname: Duvoux, Christophe
  organization: Henri Mondor University Hospital
– sequence: 8
  givenname: Jean‐Pierre
  surname: Daurès
  fullname: Daurès, Jean‐Pierre
  organization: Languedoc Mutualité
– sequence: 9
  givenname: Paul
  surname: Landais
  fullname: Landais, Paul
  organization: Nîmes University Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28140515$$D View this record in MEDLINE/PubMed
https://hal.science/hal-01897350$$DView record in HAL
BookMark eNp1kc1OGzEUhS2UCkJg0ReoLHXTLkJ87fnzMoIAkSIhVYWt5Rl7GtOJndozKdn10fEwNEit8MaW_enc43NO0cg6qxH6COQC4po1ZncBjOXFERpDkhdTRhmMDmfKTtBpCI-EAOcpHKMTWkBCUkjH6M_iqdXeygbvZGOUbI2z2NW4XWt85azz-JsJP_HSKv2EpVUvD4vOu9ZLG7aNtO3_XJTosWuvbbXG0Z32-I0fZnj9w4TW78_Qh1o2QZ-_7hN0f734fnk7Xd3dLC_nq2nFiviLrKIlp5AnimYlhyyXpeKVqhRTdQ1lnlFGEk4yLlWeMCnTmhSlzkDqMkJEsgn6OuiuZSO23myk3wsnjbidr0R_R6DgOUvJDiL7ZWC33v3qdGjFxoRKN9G9dl0QUGQxVchishP0-R_00XV9npHitM-YUPY2vPIuBK_rgwMgoq9QxJDES4WR_fSq2JUbrQ7k384iMBuA36bR-_eVxGr5MEg-AwSUp9I
CitedBy_id crossref_primary_10_1111_ajt_14992
crossref_primary_10_1007_s42058_023_00127_8
crossref_primary_10_1111_liv_13507
crossref_primary_10_1097_TP_0000000000002069
crossref_primary_10_1097_TP_0000000000002613
crossref_primary_10_1080_00365521_2022_2137691
crossref_primary_10_1038_s41598_020_60973_9
crossref_primary_10_1111_liv_13499
crossref_primary_10_1097_TXD_0000000000000896
crossref_primary_10_1097_TP_0000000000003550
crossref_primary_10_1002_mrm_28592
crossref_primary_10_1016_j_jhepr_2020_100118
crossref_primary_10_1097_MOT_0000000000000518
crossref_primary_10_17235_reed_2018_5473_2018
crossref_primary_10_1038_s41598_018_27960_7
crossref_primary_10_1016_j_clinre_2020_09_015
crossref_primary_10_1111_tri_13861
Cites_doi 10.1093/biomet/92.4.965
10.1136/bmj.b606
10.1111/j.1600-6143.2006.01242.x
10.1186/1477-5751-12-18
10.1053/j.gastro.2012.05.052
10.1002/sim.4780100805
10.1080/07357900802572110
10.1111/j.1600-6143.2007.02086.x
10.1097/01.sla.0000234896.18207.fa
10.1002/sim.1621
10.1001/jama.1982.03320430047030
10.1111/j.1600-6143.2012.04195.x
10.1002/lt.22447
10.1186/1471-2288-13-33
10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2
10.7326/M14-0698
ContentType Journal Article
Copyright 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
2017 John Wiley & Sons A/S
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
– notice: 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
– notice: 2017 John Wiley & Sons A/S
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QO
7T5
7U9
8FD
FR3
H94
P64
RC3
7X8
1XC
DOI 10.1111/liv.13378
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Biotechnology Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Virology and AIDS Abstracts
Biotechnology Research Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
CrossRef
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1478-3231
EndPage 1238
ExternalDocumentID oai_HAL_hal_01897350v1
10_1111_liv_13378
28140515
LIV13378
Genre article
Validation Studies
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations France
GeographicLocations_xml – name: France
GrantInformation_xml – fundername: French Ministry of Health
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OC
29L
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
ZXP
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QO
7T5
7U9
8FD
FR3
H94
P64
RC3
7X8
1XC
ID FETCH-LOGICAL-c3878-6c2b92174d26b9167abd9cdcd3dff1b7623049069ad743aa5f08be61aebdcd0a3
IEDL.DBID DR2
ISSN 1478-3223
IngestDate Tue Oct 15 15:17:43 EDT 2024
Fri Aug 16 05:10:48 EDT 2024
Thu Oct 10 22:08:37 EDT 2024
Fri Aug 23 02:26:16 EDT 2024
Wed Oct 16 00:59:54 EDT 2024
Sat Aug 24 00:58:45 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords external validation
prognostic score
donor risk
liver transplantation
Language English
License 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3878-6c2b92174d26b9167abd9cdcd3dff1b7623049069ad743aa5f08be61aebdcd0a3
Notes Funding information
The present study belongs to the program entitled « Optimatch ». It was funded by the French Ministry of Health within the framework of the national Clinical Research Hospital Program.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-6161-8037
0000-0002-1695-789X
0000-0003-4244-5588
0000-0002-4166-8432
PMID 28140515
PQID 1920515023
PQPubID 2045125
PageCount 10
ParticipantIDs hal_primary_oai_HAL_hal_01897350v1
proquest_miscellaneous_1863221622
proquest_journals_1920515023
crossref_primary_10_1111_liv_13378
pubmed_primary_28140515
wiley_primary_10_1111_liv_13378_LIV13378
PublicationCentury 2000
PublicationDate August 2017
2017-08-00
20170801
2017-08
PublicationDateYYYYMMDD 2017-08-01
PublicationDate_xml – month: 08
  year: 2017
  text: August 2017
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Liver international
PublicationTitleAlternate Liver Int
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
Wiley-Blackwell
Publisher_xml – name: Wiley Subscription Services, Inc
– name: Wiley-Blackwell
References 2015; 162
2012; 143
2000; 19
2013; 13
1991; 10
2013; 12
2004; 23
2006; 6
2008; 8
2012; 18
1982; 247
2016
2005; 92
2009; 338
2012; 12
2006; 244
2009; 27
28632324 - Liver Int. 2017 Oct;37(10):1572-1573
28940954 - Liver Int. 2017 Oct;37(10):1573
e_1_2_10_12_1
R Development Core Team (e_1_2_10_14_1) 2016
e_1_2_10_9_1
e_1_2_10_13_1
e_1_2_10_10_1
e_1_2_10_11_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_3_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_8_1
e_1_2_10_7_1
e_1_2_10_15_1
References_xml – volume: 6
  start-page: 783
  year: 2006
  end-page: 790
  article-title: Characteristics associated with liver graft failure: the concept of a donor risk index
  publication-title: Am J Transplant
– volume: 244
  start-page: 439
  year: 2006
  end-page: 450
  article-title: Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival
  publication-title: Ann Surg
– volume: 23
  start-page: 723
  year: 2004
  end-page: 748
  article-title: A new measure of prognostic separation in survival data
  publication-title: Stat Med
– volume: 162
  start-page: W1
  year: 2015
  end-page: W73
  article-title: Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration
  publication-title: Ann Intern Med
– volume: 247
  start-page: 2543
  year: 1982
  end-page: 2546
  article-title: Evaluating the yield of medical tests
  publication-title: JAMA
– volume: 19
  start-page: 3401
  year: 2000
  end-page: 3415
  article-title: Validation, calibration, revision and combination of prognostic survival models
  publication-title: Stat Med
– year: 2016
  publication-title: A Language and Environment for Statistical Computing
– volume: 338
  start-page: b606
  year: 2009
  article-title: Prognosis and prognostic research: application and impact of prognostic models in clinical practice
  publication-title: BMJ
– volume: 143
  start-page: 986
  year: 2012
  end-page: 994
  article-title: Liver transplantation for hepatocellular carcinoma: a model including α‐fetoprotein improves the performance of Milan criteria
  publication-title: Gastroenterology
– volume: 8
  start-page: 419
  year: 2008
  end-page: 425
  article-title: The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality
  publication-title: Am J Transplant
– volume: 27
  start-page: 235
  year: 2009
  article-title: Prognostic models: a methodological framework and review of models for breast cancer
  publication-title: Cancer Invest
– volume: 18
  start-page: 112
  year: 2012
  end-page: 119
  article-title: Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region
  publication-title: Liver Transpl
– volume: 10
  start-page: 1213
  year: 1991
  end-page: 1226
  article-title: Validation techniques for logistic regression models
  publication-title: Stat Med
– volume: 92
  start-page: 965
  year: 2005
  end-page: 970
  article-title: Concordance probability and discriminatory power in proportional hazards regression
  publication-title: Biometrika
– volume: 12
  start-page: 1
  year: 2013
  article-title: Prognostic limitations of the Eurotransplant‐donor risk index in liver transplantation
  publication-title: J Negat Results Biomed
– volume: 13
  start-page: 33
  year: 2013
  article-title: External validation of a Cox prognostic model: principles and methods
  publication-title: BMC Med Res Methodol
– volume: 12
  start-page: 2789
  year: 2012
  end-page: 2796
  article-title: The Eurotransplant donor risk index in liver transplantation: ET‐DRI
  publication-title: Am J Transplant
– ident: e_1_2_10_12_1
  doi: 10.1093/biomet/92.4.965
– ident: e_1_2_10_18_1
  doi: 10.1136/bmj.b606
– ident: e_1_2_10_4_1
  doi: 10.1111/j.1600-6143.2006.01242.x
– ident: e_1_2_10_16_1
  doi: 10.1186/1477-5751-12-18
– ident: e_1_2_10_6_1
  doi: 10.1053/j.gastro.2012.05.052
– ident: e_1_2_10_10_1
  doi: 10.1002/sim.4780100805
– ident: e_1_2_10_17_1
  doi: 10.1080/07357900802572110
– year: 2016
  ident: e_1_2_10_14_1
  publication-title: A Language and Environment for Statistical Computing
  contributor:
    fullname: R Development Core Team
– ident: e_1_2_10_7_1
  doi: 10.1111/j.1600-6143.2007.02086.x
– ident: e_1_2_10_3_1
  doi: 10.1097/01.sla.0000234896.18207.fa
– ident: e_1_2_10_13_1
  doi: 10.1002/sim.1621
– ident: e_1_2_10_11_1
  doi: 10.1001/jama.1982.03320430047030
– ident: e_1_2_10_2_1
  doi: 10.1111/j.1600-6143.2012.04195.x
– ident: e_1_2_10_5_1
  doi: 10.1002/lt.22447
– ident: e_1_2_10_8_1
  doi: 10.1186/1471-2288-13-33
– ident: e_1_2_10_9_1
  doi: 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2
– ident: e_1_2_10_15_1
  doi: 10.7326/M14-0698
SSID ssj0019951
Score 2.3431597
Snippet Background & Aims A major limitation to liver transplantation is organ shortage leading to the use of non‐optimal liver grafts. The Donor Risk Index has been...
A major limitation to liver transplantation is organ shortage leading to the use of non-optimal liver grafts. The Donor Risk Index has been validated and...
Abstract Background & Aims A major limitation to liver transplantation is organ shortage leading to the use of non‐optimal liver grafts. The Donor Risk Index...
Background & Aims A major limitation to liver transplantation is organ shortage leading to the use of non-optimal liver grafts. The Donor Risk Index has been...
BACKGROUND & AIMSA major limitation to liver transplantation is organ shortage leading to the use of non-optimal liver grafts. The Donor Risk Index has been...
BACKGROUND & AIMS:A major limitation to liver transplantation is organ shortage leading to the use of non-optimal liver grafts. The Donor Risk Index has been...
SourceID hal
proquest
crossref
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1229
SubjectTerms Adaptive systems
Adolescent
Adult
Aged
Child
Child, Preschool
donor risk
external validation
Female
France
Grafts
Human health and pathology
Humans
Hépatology and Gastroenterology
Infant
Life Sciences
Liver
Liver Transplantation
Male
Middle Aged
Optimization
Organs
prognostic score
Registries
Risk
Risk Assessment
Tissue Donors - statistics & numerical data
Transplantation
Transplants & implants
Young Adult
Title External validation of the Donor Risk Index and the Eurotransplant Donor Risk Index on the French liver transplantation registry
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fliv.13378
https://www.ncbi.nlm.nih.gov/pubmed/28140515
https://www.proquest.com/docview/1920515023
https://search.proquest.com/docview/1863221622
https://hal.science/hal-01897350
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4Bh4oLbXkGKDKoQlyyivNwEnFaUVZLBT0gQByQIj8SsWKbIHYXiZ760zvjPCigSqi3KJ44Tjxjf2OPvwH4qmUoiqjgbsy5cUOjQlf52rgmMoEuYru4T9EWP8TwMvx-HV3PwWF7Fqbmh-gW3Mgy7HhNBi7V5C8jH48ee-hgxXTQl4j0CBCdd9RRdPLYOlshbf_jHNiwClEUT_fki7lo_pYiId_CzJeo1U47g49w0za4jja5682mqqd_veJy_M8v-gRLDRxl_Vp_PsNcXi7DSr9EV_znE9tnNkDUrrwvw4ezZh9-BX4fN-TRDBV1VKdlYlXBEE2yb1VZPbDz0eSOnRAVI5OlsQW08D-1XOpj7M63clgFiQ3o_OEtG1PACHuWr99BeSQoPd0qXA6OL46GbpPLwdVBgl0gtK9Scn-MLxRC0lgqk2qjTWCKgisckmm_zxOpNIhppIwKL1G54DJXKOTJYA0WyqrMN4CJMDYonkiFvpBQMjUC9crjSqeekko7sNf2anZfU3ZkrauDbc_sL0Yh7O-unEi2h_3TjO55PEnjIPIeuQPbrTpkjWlPMoTElBcHsY4Du10xGiXttMgyr2YokwjUOS5834H1Wo26V_nEMYYVOHBgleHfbcxOT67sxeb7Rbdg0SfgYUMUt2Fh-jDLvyBsmqodax9_AFWFFDc
link.rule.ids 230,315,786,790,891,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZT9wwEB5xSLQvlKNHWmhdhFBfsopzOInUl1VhtdCFBwSIFxT5SMSKbVLBLhJ96k_vjHNwqVLVtySeJN71TPzNePwNwLaWoSiigrsx58YNjQpd5WvjmsgEuohtcJ-yLY7E8DQ8OI_O5-Bruxem5ofoAm5kGfZ7TQZOAekHVj4Z3_bQw4qTeVhEc4_ILHePO_Io2nts3a2QEgBwFmx4hSiPp7v10Ww0f0m5kM-B5mPcaieewSu4aLtc55tc9WZT1dO_nrA5_u9vWoHlBpGyfq1CqzCXl2uw3i_RG_9xx3aYzRG1wfc1WDpsluLX4fdewx_NUFfHdWUmVhUMASXbrcrqmh2Pb67YPrExMlka20Cx_6mlU5_giD6Xw0eQ2IC2IF6yCeWMsHv5-h1USoIq1L2G08Heybeh25RzcHWQ4BgI7auUPCDjC4WoNJbKpNpoE5ii4Aq_yrTk54lUGoQ1UkaFl6hccJkrFPJk8AYWyqrM3wETYWxQPJEK3SGhZGoEqpbHlU49JZV2YKsd1uxnzdqRtd4O9j2zfzEK4YB37cSzPeyPMrrm8SSNg8i75Q5stPqQNdZ9kyEqptI4CHcc-Nw1o13SYoss82qGMolApePC9x14W-tR9yqfaMbwAQ58sdrw9z5mo_0ze_D-30U_wYvhyeEIz4--f4CXPuEQm7G4AQvT61m-iShqqj5aY_kDkJQYVw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9RAEJ8AJsQXRUCtgK7GGF966W7bbRufLhyXQ5EYIoQHk2Y_2nDhbAnckeCTf7oz2w9EYmJ8a7vT7rY70_3N7uxvAN4aFckyLrmfcG79yOrI18JY38Y2NGXiJvcp2uJQTo6jj6fx6RJ86PbCNPwQ_YQbWYb7X5OBX9jyNyOfTa8H6GAl6TI8iGQoyPMaHfXcUbT12HlbEa3_4yDY0gpRGE9_653BaPmMQiHv48y7sNWNO-PH8K1rcRNucj5YzPXA_PiDzPE_X2kNHrV4lA0bBXoCS0W1DhvDCn3x7zfsHXMRom7qfR1WP7cL8Rvwc69lj2aoqdMmLxOrS4Zwko3qqr5kR9Orc7ZPXIxMVdYV0Mz_3JGpz7A_78vhI0hsTBsQz9iMIkbYrXxTByWSoPx0m3A83vu6O_HbZA6-CVPsAmmEzsj_sUJqxKSJ0jYz1tjQliXX-E-mBb9AZsoiqFEqLoNUF5KrQqNQoMKnsFLVVfEcmIwSi-Kp0ugMSa0yK1GxAq5NFmiljQdvul7NLxrOjrzzdbDtufvEKIT93ZcTy_ZkeJDTtYCnWRLGwTX3YLtTh7y17ascMTElxkGw48HrvhitkpZaVFXUC5RJUSMFl0J48KxRo74qQSRj-AAP3jtl-Hsb84P9E3fw4t9FX8Hql9EYTw8_bcFDQSDEhStuw8r8clHsIISa65fOVH4BPA0XBg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=External+validation+of+the+Donor+Risk+Index+and+the+Eurotransplant+Donor+Risk+Index+on+the+French+liver+transplantation+registry&rft.jtitle=Liver+international&rft.au=Winter%2C+Audrey&rft.au=F%C3%A9ray%2C+Cyrille&rft.au=Audureau%2C+Etienne&rft.au=%C3%89cochard%2C+Ren%C3%A9&rft.date=2017-08-01&rft.issn=1478-3223&rft.eissn=1478-3231&rft.volume=37&rft.issue=8&rft.spage=1229&rft.epage=1238&rft_id=info:doi/10.1111%2Fliv.13378&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_liv_13378
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-3223&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-3223&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-3223&client=summon